Stay updated on ABBV-8E12 Efficacy & Safety in Early Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the ABBV-8E12 Efficacy & Safety in Early Alzheimer's Clinical Trial page.

Latest updates to the ABBV-8E12 Efficacy & Safety in Early Alzheimer's Clinical Trial page
- Check4 days agoChange DetectedAdded the study results section with primary and secondary outcomes and safety data, and updated the Study Record Dates to reflect the posting of results.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a backend/version update with no changes to study content or presented data.SummaryDifference0.1%

- Check33 days agoChange DetectedUI/layout adjustments are visible, including revised header and panel formatting; no substantive study data or site information appear to have changed.SummaryDifference0.1%

- Check47 days agoChange DetectedNCT02880956 results were posted, including primary and secondary efficacy outcomes (e.g., CDR-SB, ADAS-Cog-14, ADCOMS) and safety data. The update adds detailed numerical results and related safety information to the Study Details page.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page shows a new site revision (Revision: v3.4.2) has been added, and the funding lapse notice along with Revision: v3.4.1 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to ABBV-8E12 Efficacy & Safety in Early Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABBV-8E12 Efficacy & Safety in Early Alzheimer's Clinical Trial page.